International Immunology, Vol 9, 905-911, Copyright © 1997 by Oxford University Press
A Godkin, T Friede, M Davenport, S Stevanovic, A Willis, D Jewell, A Hill and HG Rammensee
HLA-DQ8 (A1*0301, B1*0302) and -DQ2 (A1*0501, B1*0201) are both associated
with diseases such as insulin-dependent diabetes mellitus and coeliac
disease. We used the technique of pool sequencing to look at the
requirements of peptides binding to HLA-DQ8, and combined these data with
naturally sequenced ligands and in vitro binding assays to describe a novel
motif for HLA-DQ8. The motif, which has the same basic format as many
HLA-DR molecules, consists of four or five anchor regions, in the positions
from the N-terminus of the binding core of n, n + 3, n + 5/6 and n + 8,
i.e. P1, P4, P6/7 and P9. P1 and P9 require negative or polar residues,
with mainly aliphatic residues at P4 and P6/7. The features of the HLA-DQ8
motif were then compared to a pool sequence of peptides eluted from
HLA-DQ2. A consensus motif for the binding of a common peptide which may be
involved in disease pathogenesis is described. Neither of the
disease-associated alleles HLA-DQ2 and -DQ8 have Asp at position 57 of the
beta-chain. This Asp, if present, may form a salt bridge with an Arg at
position 79 of the alpha-chain and so alter the binding specificity of P9.
HLA-DQ2 and - DQ8 both appear to prefer negatively charged amino acids at
P9. In contrast, HLA-DQ7 (A1*0301, B1*0301), which is not associated with
diabetes, has Asp at beta 57, allowing positively charged amino acids at
P9. This analysis of the sequence features of DQ-binding peptides suggests
molecular characteristics which may be useful to predict epitopes involved
in disease pathogenesis.
ARTICLES
Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2)
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. C. Tong, G. L. Zhang, T. W. Tan, J. T. August, V. Brusic, and S. Ranganathan Prediction of HLA-DQ3.2{beta} Ligands: evidence of multiple registers in class II binding peptides Bioinformatics, May 15, 2006; 22(10): 1232 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ettinger, G. K. Papadopoulos, A. K. Moustakas, G. T. Nepom, and W. W. Kwok Allelic Variation in Key Peptide-Binding Pockets Discriminates between Closely Related Diabetes-Protective and Diabetes-Susceptible HLA-DQB1*06 Alleles J. Immunol., February 1, 2006; 176(3): 1988 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Senger, F. Maurano, M. F. Mazzeo, M. Gaita, O. Fierro, C. S. David, R. Troncone, S. Auricchio, R. A. Siciliano, and M. Rossi Identification of Immunodominant Epitopes of {alpha}-Gliadin in HLA-DQ8 Transgenic Mice following Oral Immunization J. Immunol., December 15, 2005; 175(12): 8087 - 8095. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kelemen, P. A. Gottlieb, A. L. Putnam, H. W. Davidson, D. R. Wegmann, and J. C. Hutton HLA-DQ8-Associated T Cell Responses to the Diabetes Autoantigen Phogrin (IA-2{beta}) in Human Prediabetes J. Immunol., March 15, 2004; 172(6): 3955 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity J. Immunol., November 1, 2002; 169(9): 5098 - 5108. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suri, I. Vidavsky, K. van der Drift, O. Kanagawa, M. L. Gross, and E. R. Unanue In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket J. Immunol., February 1, 2002; 168(3): 1235 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Godkin, K. J. Smith, A. Willis, M. V. Tejada-Simon, J. Zhang, T. Elliott, and A. V. S. Hill Naturally Processed HLA Class II Peptides Reveal Highly Conserved Immunogenic Flanking Region Sequence Preferences That Reflect Antigen Processing Rather Than Peptide-MHC Interactions J. Immunol., June 1, 2001; 166(11): 6720 - 6727. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Snijders, D. G. Elferink, A. Geluk, A. L. van der Zanden, K. Vos, G. M. T. Schreuder, F. C. Breedveld, R. R. P. de Vries, and E. H. Zanelli An HLA-DRB1-Derived Peptide Associated with Protection Against Rheumatoid Arthritis Is Naturally Processed by Human APCs J. Immunol., April 15, 2001; 166(8): 4987 - 4993. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Moustakas, Y. van de Wal, J. Routsias, Y. M. C. Kooy, P. van Veelen, J. W. Drijfhout, F. Koning, and G. K. Papadopoulos Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes Int. Immunol., August 1, 2000; 12(8): 1157 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y VAN DE WAL, Y KOOY, P VAN VEELEN, W VADER, F KONING, and S PENA Coeliac disease: it takes three to tango! Gut, May 1, 2000; 46(5): 734 - 737. [Full Text] [PDF] |
||||
![]() |
H. Arentz-Hansen, R. Korner, O. Molberg, H. Quarsten, W. Vader, Y. M.C. Kooy, K. E.A. Lundin, F. Koning, P. Roepstorff, L. M. Sollid, et al. The Intestinal T Cell Response to {alpha}-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase J. Exp. Med., February 21, 2000; 191(4): 603 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Herman, R. M. Tisch, S. D. Patel, S. L. Parry, J. Olson, J. A. Noble, A. P. Cope, B. Cox, M. Congia, and H. O. McDevitt2 Determination of Glutamic Acid Decarboxylase 65 Peptides Presented by the Type I Diabetes-Associated HLA-DQ8 Class II Molecule Identifies an Immunogenic Peptide Motif J. Immunol., December 1, 1999; 163(11): 6275 - 6282. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. van de Wal, Y. Kooy, P. van Veelen, S. Pena, L. Mearin, G. Papadopoulos, and F. Koning Cutting Edge: Selective Deamidation by Tissue Transglutaminase Strongly Enhances Gliadin-Specific T Cell Reactivity J. Immunol., August 15, 1998; 161(4): 1585 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Godkin, M. P. Davenport, A. Willis, D. P. Jewell, and A. V. S. Hill Use of Complete Eluted Peptide Sequence Data from HLA-DR and -DQ Molecules to Predict T Cell Epitopes, and the Influence of the Nonbinding Terminal Regions of Ligands in Epitope Selection J. Immunol., July 15, 1998; 161(2): 850 - 858. [Abstract] [Full Text] [PDF] |
||||




